Cargando…
Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial
BACKGROUND: Immunity to mosquito salivary proteins could provide protection against multiple mosquito-borne diseases and significantly impact public health. We evaluated the safety and immunogenicity of AGS-v PLUS, a mosquito salivary peptide vaccine, in healthy adults 18–50 years old. METHODS: We c...
Autores principales: | Friedman-Klabanoff, DeAnna J., Birkhold, Megan, Short, Mara T., Wilson, Timothy R., Meneses, Claudio R., Lacsina, Joshua R., Oliveira, Fabiano, Kamhawi, Shaden, Valenzuela, Jesus G., Hunsberger, Sally, Mateja, Allyson, Stoloff, Gregory, Pleguezuelos, Olga, Memoli, Matthew J., Laurens, Matthew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700263/ https://www.ncbi.nlm.nih.gov/pubmed/36436281 http://dx.doi.org/10.1016/j.ebiom.2022.104375 |
Ejemplares similares
-
The PAGODAS protocol: pediatric assessment group of dengue and Aedes saliva protocol to investigate vector-borne determinants of Aedes-transmitted arboviral infections in Cambodia
por: Manning, Jessica E., et al.
Publicado: (2018) -
Vector Saliva in Vaccines for Visceral Leishmaniasis: A Brief Encounter of High Consequence?
por: Kamhawi, Shaden, et al.
Publicado: (2014) -
Saliva collection via capillary method may underestimate arboviral transmission by mosquitoes
por: Gloria-Soria, A., et al.
Publicado: (2022) -
Immunity to vector saliva is compromised by short sand fly seasons in endemic regions with temperate climates
por: Oliveira, Fabiano, et al.
Publicado: (2020) -
Sequential blood meals augment vector infectiousness by promoting Leishmania replication and triggering amplification of metacyclics via a novel retroleptomonad developmental stage
por: Serafim, Tiago D., et al.
Publicado: (2018)